The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular ...

Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one ...

PITTSBURGH (KDKA) — A popular diabetes medication will be in short supply for much longer than previously expected. Now, pharmacists and Pittsburgh-area patients like Mark Allen are scrambling. Allen ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes. Weight ...

News 8 On Your Side is investigating a critical drug shortage frustrating diabetics who need the medicine.Investigator Susan Shapiro looked into the shortage and what the drug maker had to say about ...